| Company | Designation | Period |
|---|---|---|
| Glenmark Pharmaceuticals | Vice President & Head - Asia | Nov 2016 – Aug 2017 |
| Ranbaxy | Manager-International Marketing & Development | Nov 2003 – Dec 2006 |
| Lupin | Medical Representative | Jul 1998 – Jun 2001 |
| Ranbaxy | Area Manager-North Africa | Jan 2010 – Jan 2011 |
| Ranbaxy | Senior Manager-ARV Business | Jan 2008 – Jan 2010 |
| Ranbaxy | Manager-ARV Business | Jan 2007 – Dec 2007 |
| Ranbaxy Morocco LLC | Area Manager-North Africa & Directeur Général | Feb 2011 – Mar 2015 |
| Sun Pharmaceuticals Morocco LLC | Area Manager-North Africa & Directeur Général | Apr 2015 – Nov 2016 |
| Alembic | MT-Business Development | Apr 2003 – Oct 2003 |
| RV Group | Director | Sep 2017 – Present |
| InQure Health | Co-Founder & Group Director | Jul 2018 – Present |
Estimated Range: ₹0 – ₹1000+ Cr (approx. $0 – $120M+)
Based on publicly accessible filings, industry benchmarks, and leadership compensation patterns.
Official Email: Via Inqure Health corporate communication desk.
Personal Contact: Not publicly disclosed.
What is Atul Chhabra's net worth?
Estimated ₹0 – ₹1000+ Cr (approx. $0 – $120M+).
How can I contact them?
Through Inqure Health's official communication channels.
Is this an official profile?
No — independently created using public data.
This profile is created for general informational purposes. All details are based on publicly accessible information and independent research. While accuracy is prioritized, content may not always reflect the latest updates.
Nothing here should be interpreted as investment, financial, or legal advice. The individual featured has not authored or endorsed this profile.
Personal information is intentionally withheld. For official matters, please use formal communication channels associated with the respective organization.
Affluense AI – Smarter Insights. Stronger Relationships with Affluents.
Last Updated: December 2025 · Published by Affluense AI (affluense.ai)